1	Anti-Ehrlichia	anti-ehrlichia	_	_	_	_	_	_	_
2	chaffeensis	chaffeensis	_	_	_	_	_	_	_
3	antibody	antibody	_	_	_	_	_	_	_
4	complexed	complexe	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	E.	e.	_	_	_	_	_	_	_
7	chaffeensis	chaffeensis	_	_	_	_	_	_	_
8	induces	induce	_	_	_	_	_	_	_
9	potent	potent	_	_	_	_	_	_	_
10	proinflammatory	proinflammatory	_	_	_	_	_	_	_
11	cytokine	cytokine	_	_	_	_	_	_	_
12	mRNA	mrna	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	human	human	_	_	_	_	_	_	_
16	monocytes	monocyte	_	_	_	_	_	_	_
17	through	through	_	_	_	_	_	_	_
18	sustained	sustained	_	_	_	_	_	_	_
19	reduction	reduction	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	IkappaB-alpha	IkappaB-alpha	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	activation	activation	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Ehrlichia	ehrlichia	_	_	_	_	_	_	_
2	chaffeensis	chaffeensis	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	an	an	_	_	_	_	_	_	_
5	obligatory	obligatory	_	_	_	_	_	_	_
6	intracellular	intracellular	_	_	_	_	_	_	_
7	bacterium	bacterium	_	_	_	_	_	_	_
8	that	that	_	_	_	_	_	_	_
9	infects	infect	_	_	_	_	_	_	_
10	monocytes	monocyte	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	macrophages	macrophage	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	is	be	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	etiologic	etiologic	_	_	_	_	_	_	_
17	agent	agent	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	human	human	_	_	_	_	_	_	_
20	ehrlichiosis	ehrlichiosis	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	United	United	_	_	_	_	_	_	_
24	States	State	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	previous	previous	_	_	_	_	_	_	_
3	studies	study	_	_	_	_	_	_	_
4	showed	show	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	exposure	exposure	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	monocytes	monocyte	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	E.	e.	_	_	_	_	_	_	_
13	chaffeensis	chaffeensis	_	_	_	_	_	_	_
14	induces	induce	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	expression	expression	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	interleukin-1beta	interleukin-1beta	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	IL-1beta	IL-1beta	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	IL-8	il-8	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	IL-10	il-10	_	_	_	_	_	_	_
27	genes	gene	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	vitro	vitro	_	_	_	_	_	_	_
30	but	but	_	_	_	_	_	_	_
31	not	not	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	expression	expression	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	tumor	tumor	_	_	_	_	_	_	_
36	necrosis	necrosis	_	_	_	_	_	_	_
37	factor	factor	_	_	_	_	_	_	_
38	alpha	alpha	_	_	_	_	_	_	_
39	(	(	_	_	_	_	_	_	_
40	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
41	)	)	_	_	_	_	_	_	_
42	and	and	_	_	_	_	_	_	_
43	IL-6	IL-6	_	_	_	_	_	_	_
44	mRNAs	mrna	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	effect	effect	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	anti-E.	anti-e.	_	_	_	_	_	_	_
9	chaffeensis	chaffeensis	_	_	_	_	_	_	_
10	antibody	antibody	_	_	_	_	_	_	_
11	complexed	complexe	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	E.	e.	_	_	_	_	_	_	_
14	chaffeensis	chaffeensis	_	_	_	_	_	_	_
15	on	on	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	expression	expression	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	major	major	_	_	_	_	_	_	_
20	proinflammatory	proinflammatory	_	_	_	_	_	_	_
21	cytokines	cytokine	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	human	human	_	_	_	_	_	_	_
24	monocytes	monocyte	_	_	_	_	_	_	_
25	was	be	_	_	_	_	_	_	_
26	examined	examine	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Human	human	_	_	_	_	_	_	_
2	monocytic	monocytic	_	_	_	_	_	_	_
3	cell	cell	_	_	_	_	_	_	_
4	line	line	_	_	_	_	_	_	_
5	THP-1	thp-1	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	treated	treat	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	E.	e.	_	_	_	_	_	_	_
10	chaffeensis	chaffeensis	_	_	_	_	_	_	_
11	which	which	_	_	_	_	_	_	_
12	had	have	_	_	_	_	_	_	_
13	been	be	_	_	_	_	_	_	_
14	preincubated	preincubate	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	human	human	_	_	_	_	_	_	_
17	anti-E.	anti-e.	_	_	_	_	_	_	_
18	chaffeensis	chaffeensis	_	_	_	_	_	_	_
19	serum	serum	_	_	_	_	_	_	_
20	for	for	_	_	_	_	_	_	_
21	2	2	_	_	_	_	_	_	_
22	h	h	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	levels	level	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	cytokine	cytokine	_	_	_	_	_	_	_
29	mRNAs	mrna	_	_	_	_	_	_	_
30	were	be	_	_	_	_	_	_	_
31	evaluated	evaluate	_	_	_	_	_	_	_
32	by	by	_	_	_	_	_	_	_
33	competitive	competitive	_	_	_	_	_	_	_
34	reverse	reverse	_	_	_	_	_	_	_
35	transcription-PCR	transcription-PCR	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Anti-E.	anti-e.	_	_	_	_	_	_	_
2	chaffeensis	chaffeensis	_	_	_	_	_	_	_
3	antibody	antibody	_	_	_	_	_	_	_
4	complexed	complexe	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	E.	e.	_	_	_	_	_	_	_
7	chaffeensis	chaffeensis	_	_	_	_	_	_	_
8	significantly	significantly	_	_	_	_	_	_	_
9	enhanced	enhance	_	_	_	_	_	_	_
10	mRNA	mrna	_	_	_	_	_	_	_
11	expression	expression	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	IL-1beta	IL-1beta	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	THP-1	thp-1	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	IL-6	IL-6	_	_	_	_	_	_	_
7	mRNAs	mrna	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	also	also	_	_	_	_	_	_	_
10	induced	induce	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	levels	level	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	secreted	secrete	_	_	_	_	_	_	_
5	IL-1beta	IL-1beta	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	IL-6	il-6	_	_	_	_	_	_	_
11	during	during	_	_	_	_	_	_	_
12	24	24	_	_	_	_	_	_	_
13	h	h	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	stimulation	stimulation	_	_	_	_	_	_	_
16	were	be	_	_	_	_	_	_	_
17	comparable	comparable	_	_	_	_	_	_	_
18	to	to	_	_	_	_	_	_	_
19	those	those	_	_	_	_	_	_	_
20	induced	induce	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	Escherichia	escherichia	_	_	_	_	_	_	_
23	coli	coli	_	_	_	_	_	_	_
24	lipopolysaccharide	lipopolysaccharide	_	_	_	_	_	_	_
25	at	at	_	_	_	_	_	_	_
26	1	1	_	_	_	_	_	_	_
27	microg/ml.	microg/ml.	_	_	_	_	_	_	_
28	Fab	Fab	_	_	_	_	_	_	_
29	fragment	fragment	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	anti-E.	anti-e.	_	_	_	_	_	_	_
32	chaffeensis	chaffeensis	_	_	_	_	_	_	_
33	immunoglobulin	immunoglobulin	_	_	_	_	_	_	_
34	G	G	_	_	_	_	_	_	_
35	complexed	complexe	_	_	_	_	_	_	_
36	with	with	_	_	_	_	_	_	_
37	E.	e.	_	_	_	_	_	_	_
38	chaffeensis	chaffeensis	_	_	_	_	_	_	_
39	did	do	_	_	_	_	_	_	_
40	not	not	_	_	_	_	_	_	_
41	induce	induce	_	_	_	_	_	_	_
42	any	any	_	_	_	_	_	_	_
43	of	of	_	_	_	_	_	_	_
44	these	these	_	_	_	_	_	_	_
45	three	three	_	_	_	_	_	_	_
46	cytokines	cytokine	_	_	_	_	_	_	_
47	,	,	_	_	_	_	_	_	_
48	indicating	indicate	_	_	_	_	_	_	_
49	that	that	_	_	_	_	_	_	_
50	ehrlichial	ehrlichial	_	_	_	_	_	_	_
51	binding	binding	_	_	_	_	_	_	_
52	is	be	_	_	_	_	_	_	_
53	required	require	_	_	_	_	_	_	_
54	for	for	_	_	_	_	_	_	_
55	IL-1beta	IL-1beta	_	_	_	_	_	_	_
56	mRNA	mRNA	_	_	_	_	_	_	_
57	expression	expression	_	_	_	_	_	_	_
58	and	and	_	_	_	_	_	_	_
59	that	that	_	_	_	_	_	_	_
60	binding	binding	_	_	_	_	_	_	_
61	of	of	_	_	_	_	_	_	_
62	the	the	_	_	_	_	_	_	_
63	immune	immune	_	_	_	_	_	_	_
64	complex	complex	_	_	_	_	_	_	_
65	to	to	_	_	_	_	_	_	_
66	the	the	_	_	_	_	_	_	_
67	Fc	Fc	_	_	_	_	_	_	_
68	gamma	gamma	_	_	_	_	_	_	_
69	receptor	receptor	_	_	_	_	_	_	_
70	is	be	_	_	_	_	_	_	_
71	required	require	_	_	_	_	_	_	_
72	for	for	_	_	_	_	_	_	_
73	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
74	and	and	_	_	_	_	_	_	_
75	IL-6	IL-6	_	_	_	_	_	_	_
76	mRNA	mRNA	_	_	_	_	_	_	_
77	expression	expression	_	_	_	_	_	_	_
78	and	and	_	_	_	_	_	_	_
79	enhanced	enhance	_	_	_	_	_	_	_
80	IL-1beta	IL-1beta	_	_	_	_	_	_	_
81	mRNA	mrna	_	_	_	_	_	_	_
82	expression	expression	_	_	_	_	_	_	_
83	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	prolonged	prolonged	_	_	_	_	_	_	_
4	degradation	degradation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	IkappaB-alpha	IkappaB-alpha	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
11	were	be	_	_	_	_	_	_	_
12	demonstrated	demonstrate	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	THP-1	thp-1	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	exposed	expose	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	anti-E.	anti-e.	_	_	_	_	_	_	_
19	chaffeensis	chaffeensis	_	_	_	_	_	_	_
20	serum	serum	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	E.	e.	_	_	_	_	_	_	_
23	chaffeensis	chaffeensis	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	result	result	_	_	_	_	_	_	_
3	implies	imply	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	development	development	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	anti-E.	anti-e.	_	_	_	_	_	_	_
8	chaffeensis	chaffeensis	_	_	_	_	_	_	_
9	antibody	antibody	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	patients	patient	_	_	_	_	_	_	_
12	can	can	_	_	_	_	_	_	_
13	result	result	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	production	production	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	major	major	_	_	_	_	_	_	_
19	proinflammatory	proinflammatory	_	_	_	_	_	_	_
20	cytokines	cytokine	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	which	which	_	_	_	_	_	_	_
23	may	may	_	_	_	_	_	_	_
24	play	play	_	_	_	_	_	_	_
25	an	an	_	_	_	_	_	_	_
26	important	important	_	_	_	_	_	_	_
27	role	role	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	pathophysiology	pathophysiology	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	ehrlichiosis	ehrlichiosis	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	immune	immune	_	_	_	_	_	_	_
35	responses	response	_	_	_	_	_	_	_
36	to	to	_	_	_	_	_	_	_
37	it	it	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

